The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
Abstract
The transcription factor Myc is essential for the regulation of haematopoietic stem cells and progenitors and has a critical function in haematopoietic malignancies. Here we show that an evolutionarily conserved region located 1.7 megabases downstream of the Myc gene that has previously been labelled as a 'super-enhancer' is essential for the regulation of Myc expression levels in both normal haematopoietic and leukaemic stem cell hierarchies in mice and humans. Deletion of this region in mice leads to a complete loss of Myc expression in haematopoietic stem cells and progenitors. This caused an accumulation of differentiation-arrested multipotent progenitors and loss of myeloid and B cells, mimicking the phenotype caused by Mx1-Cre-mediated conditional deletion of the Myc gene in haematopoietic stem cells. This super-enhancer comprises multiple enhancer modules with selective activity that recruits a compendium of transcription factors, including GFI1b, RUNX1 and MYB. Analysis of mice carrying deletions of individual enhancer modules suggests that specific Myc expression levels throughout most of the haematopoietic hierarchy are controlled by the combinatorial and additive activity of individual enhancer modules, which collectively function as a 'blood enhancer cluster' (BENC). We show that BENC is also essential for the maintenance of MLL-AF9-driven leukaemia in mice. Furthermore, a BENC module, which controls Myc expression in mouse haematopoietic stem cells and progenitors, shows increased chromatin accessibility in human acute myeloid leukaemia stem cells compared to blasts. This difference correlates with MYC expression and patient outcome. We propose that clusters of enhancers, such as BENC, form highly combinatorial systems that allow precise control of gene expression across normal cellular hierarchies and which also can be hijacked in malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, the combinatorial occupancy of chromatin by multiple master TFs has revealed regulatory networks that are important for hematopoiesis (Beck et al., 2013; Schütte et al., 2016), as well as key regulatory elements necessary for HSC self-renewal (Bahr et al., 2018).”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Bahr et al., 2018
In the citing paper
“Even studies at a single locus can be illuminating, as exemplified by the identification of a hematopoietic-specific enhancer of MYC that is required by HSCs (Bahr et al., 2018) (Figure 4B).”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Bahr et al., 2018
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Topological domains in mammalian genomes identified by analysis of chromatin interactions
Dixon, J. R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J. S., & Ren, B. (2012) · Nature · doi:10.1038/nature11082 · Cited by 6,829
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 337
Call, S. G., Duren, R. P., Panigrahi, A. K., Nguyen, L., Freire, P. R., Grimm, S. L., Coarfa, C., & Conneely, O. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-59469-3 · Cited by 31
Determinants and role of chromatin organization in acute leukemia
Fang, C., Rao, S., Crispino, J. D., & Ntziachristos, P. (2020) · Leukemia · doi:10.1038/s41375-020-0981-z · Cited by 30
Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically
Jiang, X., Wang, L., Xie, S., Chen, Y., Song, S., Lu, Y., & Lu, D. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02036-4 · Cited by 30
Super-enhancer-mediated core regulatory circuitry in human cancer
Jiang, Y. Y., Jiang, Y., & Lin, D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.006 · Cited by 33
Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma
Guo, W., Wang, X., Lu, B., Yu, J., Xu, M., Huang, R., Cheng, M., Yang, M., Zhao, W., & Zou, C. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05966-y · Cited by 29
Zouari, Y. B., Molitor, A., Sikorska, N., Pancaldi, V., & Sexton, T. (2018) · Genome Biology · doi:10.1186/s13059-019-1706-3 · Cited by 27
Kessler, S., Minoux, M., Joshi, O., Zouari, Y. B., Ducret, S., Ross, F., Vilain, N., Salvi, A., Wolff, J., Kohler, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38953-0 · Cited by 28
Yuan, J., Liu, X., Zhao, H., Wang, Y., Xi, W., Wang, P., Zhan, J., Liu, L., Li, F., & Ge, X. (2023) · New Phytologist · doi:10.1111/nph.19120 · Cited by 28
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis
Sommermann, T. G., Yasuda, T., Ronen, J., Wirtz, T., Weber, T., Sack, U., Caeser, R., Zhang, J., Li, X., Chu, V. T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921139117 · Cited by 28
Hashimoto, M., Saito, Y., Nakagawa, R., Ogahara, I., Takagi, S., Takata, S., Amitani, H., Endo, M., Yuki, H., Ramilowski, J. A., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00177-w · Cited by 29
The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia
Hoang, V. T., Verma, D., Godavarthy, P. S., Llavona, P., Steiner, M., Gerlach, K., Michels, B. E., Bohnenberger, H., Wachter, A., Oellerich, T., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0358-8 · Cited by 27
GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia
Liu, L., Patnana, P. K., Xie, X., Frank, D., Nimmagadda, S. C., Su, M., Zhang, D., Koenig, T., Rosenbauer, F., Liebmann, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01635-9 · Cited by 28
Etiology of super-enhancer reprogramming and activation in cancer
Zhou, R. W., & Parsons, R. E. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00502-w · Cited by 31
Zhang, C., Stelloo, E., Barrans, S., Cucco, F., Jiang, D., Tzioni, M., Chen, Z., Li, Y., Swennenhuis, J. F., Makker, J., et al. (2024) · Leukemia · doi:10.1038/s41375-023-02134-1 · Cited by 26
Enhancer and super-enhancer landscape in polycystic kidney disease
Lakhia, R., Mishra, A., Biggers, L. M., Malladi, V. S., Cobo-Stark, P., Hajarnis, S. S., & Patel, V. (2021) · Kidney International · doi:10.1016/j.kint.2022.08.039 · Cited by 23
3D Chromosomal Landscapes in Hematopoiesis and Immunity
Kloetgen, A., Thandapani, P., Tsirigos, A., & Aifantis, I. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.07.003 · Cited by 25
Montefiori, L. E., & Mullighan, C. G. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101329 · Cited by 25
Marx-Blümel, L., Marx, C., Sonnemann, J., Weise, F., Hampl, J., Frey, J., Rothenburger, L., Cirri, E., Rahnis, N., Koch, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00619-6 · Cited by 26
Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
Heudobler, D., Rechenmacher, M., Lüke, F., Vogelhuber, M., Klobuch, S., Thomas, S., Pukrop, T., Hackl, C., Herr, W., Ghibelli, L., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01357 · Cited by 24
A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia
Tottone, L., Lancho, O., Loh, J.-W., Singh, A., Kimura, S., Roels, J., Kuchmiy, A. A., Strubbe, S., Lawlor, M. A., da Silva-Diz, V., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0201 · Cited by 24
EBF1 primes B-lymphoid enhancers and limits the myeloid bias in murine multipotent progenitors
Lenaerts, A., Kuciński, I., Deboutte, W., Derecka, M., Cauchy, P., Manke, T., Göttgens, B., & Grosschedl, R. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212437 · Cited by 24
The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells
Anderson, D. A., Murphy, T. L., Eisenman, R. N., & MURPHY, K. M. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915060117 · Cited by 24
Hwang, J., Suh, C. H., Kim, K. R., Kim, H., Kim, A. I., Craig, J. W., Chen, K. X., Roberson, J., Guenette, J. P., & Huang, R. Y. (2021) · Cancers · doi:10.3390/cancers13133369 · Cited by 22
Li, X., Zeng, S., Chen, L., Zhang, Y., Li, X., Zhang, B., Su, D., Du, Q., Zhang, J., Wang, H., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13552 · Cited by 23
Causal Gene Regulatory Network Modeling and Genomics: Second-Generation Challenges
Rothenberg, E. V. (2019) · Journal of Computational Biology · doi:10.1089/cmb.2019.0098 · Cited by 20
Tan, Y., Wu, Q., & Zhou, F. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102993 · Cited by 20
Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies
Fultang, L., Gneo, L., Santo, C. D., & Mussai, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.674720 · Cited by 23
Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements
Rogers, B. B., Anderson, A. G., Lauzon, S. N., Davis, M. N., Hauser, R. M., Roberts, S. C., Rodríguez-Nunez, I., Trausch‐Lowther, K., Barinaga, E. A., Hall, P. I., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.12.015 · Cited by 21
Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc
García-Cuéllar, M.-P., Prinz, A., & Slany, R. K. (2022) · Haematologica · doi:10.3324/haematol.2022.280831 · Cited by 20
Ultimate Precision: Targeting Cancer but Not Normal Self-replication
Velcheti, V., Schrump, D. S., & Saunthararajah, Y. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_199753 · Cited by 20
Su, G., Guo, D., Chen, J., Liu, M., Zheng, J., Wang, W., Zhao, X., Yin, Q., Zhang, L., Zhao, Z., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz482 · Cited by 21
Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects
Wan, L., Li, W., Meng, Y., Hou, Y., Chen, M., & Xu, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.849451 · Cited by 20
Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution
Tomás-Daza, L., Rovirosa, L., López-Martí, P., Nieto-Aliseda, A., Serra, F., Planas‐Riverola, A., Molina, Ò., McDonald, R., Ghevaert, C., Cuatrecasas, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35911-8 · Cited by 22
Enhancer-mediated FOXO3 expression promotes MSC adipogenic differentiation by activating autophagy
Feng, P., Pang, P., Sun, Z., Xie, Z., Chen, T., Wang, S., Cao, Q., Mi, R., Zeng, C., Lu, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166975 · Cited by 19
Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
Anderson, D. A., Ou, F., Kim, S. K., Murphy, T. L., & MURPHY, K. M. M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211483 · Cited by 18
Simultaneous targeting of linked loci in mouse embryos using base editing
Lee, H., Willi, M., Smith, H. E., Miller, S. M., Liu, D. R., Liu, C., & Hennighausen, L. G. (2019) · Scientific Reports · doi:10.1038/s41598-018-33533-5 · Cited by 17
Differential regulation of myc homologs by Wnt/β‐Catenin signaling in the early metazoan Hydra
Hartl, M., Glasauer, S. M. K., Gufler, S., Raffeiner, A., Puglisi, K., Breuker, K., Bister, K., & Hobmayer, B. (2019) · FEBS Journal · doi:10.1111/febs.14812 · Cited by 18
Multi‐omics analysis reveals the functional transcription and potential translation of enhancers
Wu, Y., Yang, Y., Gu, H., Tao, B., Zhang, E., Wei, J., Wang, Z., Liu, A., Sun, R., Chen, M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33132 · Cited by 18
Benbarche, S., Lopez, C. K., Salataj, E., Aid, Z., Thirant, C., Laiguillon, M.-C., Lecourt, S., Belloucif, Y., Vaganay, C., Antonini, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abg9455 · Cited by 18
The Causes and Consequences of Spatial Organization of the Genome in Regulation of Gene Expression
Agelopoulos, M., Foutadakis, S., & Thanos, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682397 · Cited by 19
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia
Millman, S. E., Perez, A. C., Janaki‐Raman, S., Ho, Y.-J., Morris, J. P., Narendra, V. K., Chen, C.-C., Jackson, B. T., Yashinskie, J. J., Mezzadra, R., et al. (2025) · Blood · doi:10.1182/blood.2024025245 · Cited by 17
Chromatin occupancy and target genes of the haematopoietic master transcription factor MYB
Lemma, R. B., Ledsaak, M., Fuglerud, B. M., Sandve, G. K., Eskeland, R., & Gabrielsen, O. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-88516-w · Cited by 17
Curtiss, B. M., VanCampen, J., Macaraeg, J., Kong, G., Taherinasab, A., Tsuchiya, M., Yashar, W. M., Tsang, Y. H., Horton, W. R., Coleman, D. J., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01594-1 · Cited by 14
Pan, F., Iwasaki, M., Wu, W., Jiang, Y.-N., Yang, X., Zhu, L., Zhao, Z., & Cleary, M. L. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008787 · Cited by 16
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
Tang, Z., Qu, Q., Teng, X.-Q., Zhuang, H.-H., Xu, W.-X., & Qu, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1192855 · Cited by 16
Super-enhancer omics in stem cell
Ma, H., Qu, J., Pang, Z., Luo, J., Yan, M., Xu, W.-X., Zhuang, H., Liu, L., & Qu, Q. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02066-z · Cited by 23
Amjadi‐Moheb, F., Paniri, A., & Akhavan‐Niaki, H. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3613 · Cited by 16
Hong, D., Lin, H., Liu, L., Shu, M., Dai, J., Lu, F., Tong, M., & Huang, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac508 · Cited by 15
Shin, B., & Rothenberg, E. V. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1108368 · Cited by 18
Vujovic, A., de Rooij, L. P. M. H., Chahi, A. K., Chen, H. T., Yee, B. A., Loganathan, S. K., Liu, L., Chan, D. C. H., Tajik, A., Tsao, E., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0086 · Cited by 17
Das, N. D., Chang, J.-C., Hon, C.-C., Kelly, S. T., Ito, S., Lizio, M., Kaczkowski, B., Watanabe, H., Katsushima, K., Natsume, A., et al. (2023) · BMC Genomics · doi:10.1186/s12864-023-09659-w · Cited by 15
Distinct use of super-enhancer elements controls cell type–specific CD25 transcription and function
Spolski, R. J., Li, P., Chandra, V., Shin, B., Goel, S., Sakamoto, K., Liu, C., Oh, J., Ren, M., Enomoto, Y., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adi8217 · Cited by 19
The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9
Klein, D. C., Lardo, S. M., & Hainer, S. J. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0382 · Cited by 15
Controlling gene activation by enhancers through a drug-inducible topological insulator
Tsujimura, T., Takase, O., Yoshikawa, M., Sano, E., Hayashi, M., Hoshi, K., Takato, T., Toyoda, A., Okano, H., & Hishikawa, K. (2020) · eLife · doi:10.7554/elife.47980 · Cited by 16
Three-dimensional regulatory hubs support oncogenic programs in glioblastoma
Breves, S. L., Giammartino, D. C. D., Nicholson, J., Cirigliano, S. M., Mahmood, S. R., Lee, U. J., Martinez‐Fundichely, A., Jungverdorben, J., Singhania, R., Rajkumar, S., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2025.03.007 · Cited by 15
Yao, J., Liu, Y., Yang, J., Li, M., Li, S., Zhang, B., Yang, R., Zhang, Y., Cui, X., & Feng, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.904536 · Cited by 14
Radzisheuskaya, A., Peña-Rømer, I., Lorenzini, E., Koche, R., Zhan, Y.-Q. A., Shliaha, P. V., Cooper, A. J., Fan, Z., Shlyueva, D., Johansen, J., et al. (2023) · EMBO Journal · doi:10.15252/embj.2023114221 · Cited by 13
Mapping Active Gene-Regulatory Regions in Human Repopulating Long-Term HSCs
Wünsche, P., Eckert, E., Holland‐Letz, T., Paruzynski, A., Hotz‐Wagenblatt, A., Fronza, R., Rath, T., Gil-Fariña, I., Schmidt, M., Kalle, C. V., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.06.003 · Cited by 14
Tu, X., Li, C., Sun, W. Y., Tian, X., Li, Q., Wang, S., Ding, X., & Huang, Z. (2023) · Cancers · doi:10.3390/cancers15030930 · Cited by 14
Wu, W., Johansson, G. K., Wibom, C., Brännström, T., Malmström, A., Henriksson, R., Golovleva, I., Bondy, M. L., Andersson, U., Dahlin, A. M., et al. (2019) · Cancers · doi:10.3390/cancers11122001 · Cited by 14
Cisinteractions in theIrf8locus regulate stage-dependent enhancer activationPreprint
Liu, T., Ou, F., Belk, J. A., Bagadia, P., Anderson, D. A., Durai, V., Yao, W., Satpathy, A. T., Murphy, T. L., & MURPHY, K. M. M. (2023) · Genes & Development · doi:10.1101/gad.350339.122 · Cited by 13
Single-cell response to Wnt signaling activation reveals uncoupling of Wnt target gene expression
Söderholm, S., Jauregi‐Miguel, A., Pagella, P., Ghezzi, V., Zambanini, G., Nordin, A., & Cantù, C. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113646 · Cited by 13
Meng, Y., Cao, Y., He, J., Dong, R., Liu, G., Chen, Y., Wang, J., & Zhou, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1367230 · Cited by 13
The Interplay of Transcription and Genome Topology Programs T Cell Development and Differentiation
Zhao, X., Zhu, S., Peng, W., & Xue, H. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200625 · Cited by 14
Edrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2023) · Genome biology · doi:10.1186/s13059-023-03094-6 · Cited by 12
Li-Bao, L., Díaz-Díaz, C., Raiola, M., Sierra, R., Temiño, S., Moya, F., Rodríguez, S., Santos, E., Giovinazzo, G., Bleckwehl, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48258-5 · Cited by 12
Repurposing of Anticancer Stem Cell Drugs in Brain Tumors
Bahmad, H. F., Daher, D., Aljamal, A. A., Elajami, M. K., Oh, K. S., Moreno, J. C. A., Delgado, R. G., Suarez, R., Zaldivar, A., Azimi, R., et al. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211025482 · Cited by 12
Building a Mammalian Retina: An Eye on Chromatin Structure
Daghsni, M., & Aldiri, I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.775205 · Cited by 11
Yu, Q., Wang, P., Yang, L., Wu, Z., Li, S., Xu, Y., Wu, B., Ma, A., Gan, X., & Xu, R. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109134 · Cited by 12
Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia
Belver, L., Alberó, R., & Ferrando, A. A. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.03.005 · Cited by 13
Cheng, C., Yung, Y., Chan, H., Leung, K. T., Chan, K. Y. Y., Leung, A. W. K., Cheng, F. W. T., Li, C. K., Wan, T. S. K., Luo, X., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04732-2 · Cited by 11
Vízkeleti, L., & Spisák, S. (2023) · Cells · doi:10.3390/cells12131745 · Cited by 10
Feng, Q., Cui, N., Li, S., Cao, J., Chen, Q., & Wang, H.-Y. (2023) · The FASEB Journal · doi:10.1096/fj.202201596rrr · Cited by 12
Deregulation of Transcriptional Enhancers in Cancer
Azad, F. M., & Atlasi, Y. (2021) · Cancers · doi:10.3390/cancers13143532 · Cited by 12
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels
Portilla, A. L. D. L., Ekdahl, L., Cafaro, C., Ali, Z., Miharada, N., Þorleifsson, G., Žemaitis, K., Arrizabalaga, A. L., Thodberg, M., Pertesi, M., et al. (2022) · Blood · doi:10.1182/blood.2021013220 · Cited by 11
Liu, C., Jiang, Y., Zhao, Z., Wu, H., Zhang, L., Yang, Z., Hoffman, R. M., & Zheng, J. (2019) · Anticancer Research · doi:10.21873/anticanres.13399 · Cited by 11
Transcriptional regulation of MYC through G-quadruplex structures
Balaratnam, S., & Schneekloth, J. S. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.05.002 · Cited by 12
Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate
Xu, Y. J., Liu, J., Chen, W.-J., Ye, Q., Chen, W., Li, C., & Wu, H.-T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.561703 · Cited by 11
Enhancer rewiring in tumors: an opportunity for therapeutic intervention
Richart, L., Bidard, F., & Margueron, R. (2021) · Oncogene · doi:10.1038/s41388-021-01793-7 · Cited by 12
Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia
Pingul, B. Y., Huang, H., Chen, Q., Alikarami, F., Zhang, Z., Qi, J., Bernt, K. M., Berger, S. L., Cao, Z., & Shi, J. (2022) · iScience · doi:10.1016/j.isci.2022.105139 · Cited by 10
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
Wang, H., Sun, H., Liang, B., Zhang, F., Yang, F., Cui, B., Ding, L., Wang, X., Wang, R., Cai, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42565-z · Cited by 9
Oncogenic Enhancers in Leukemia
Mulet‐Lazaro, R., & Delwel, R. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0211 · Cited by 11
Targeting pivotal amino acids metabolism for treatment of leukemia
Hong, J., Liu, W., Xiao, X., Gajendran, B., & Ben‐David, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40492 · Cited by 10
Yashar, W. M., Curtiss, B. M., Coleman, D. J., VanCampen, J., Kong, G., Macaraeg, J., Estabrook, J., Demir, E., Long, N., Bottomly, D., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0745 · Cited by 10
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Shlush, L. I., & Feldman, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13236 · Cited by 10
Li, F., Gao, C., Li, X., Wang, J., Zhao, Y., Ke, Y., Liu, Y., Liu, H., Hu, Z., Wei, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1001552 · Cited by 10
Regulatory Landscapes of Nppa and Nppb
Sobreira, D. R., & Nóbrega, M. A. (2021) · Circulation Research · doi:10.1161/circresaha.120.318495 · Cited by 10
Functional genomic assays to annotate enhancer–promoter interactions genome wide
Leung, A. K.-Y., Li, Y., & Yu, H. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac204 · Cited by 9
Zhu, X., Zhang, Y., Yin, Z., Ye, Z., Qin, Y., Cheng, Z., Shen, Y., Yin, Z., Ma, J., Tang, Y., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42703 · Cited by 10
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis
Mulet‐Lazaro, R., & Delwel, R. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000969 · Cited by 11
Caragine, C. M., Le, V. T., Mustafa, M., Diaz, B. J., Morris, J. A., Müller, S., Méndez‐Mancilla, A., Geller, E. T., Liscovitch‐Brauer, N., & Sanjana, N. E. (2025) · Nature Communications · doi:10.1038/s41467-025-56568-5 · Cited by 9
Mammalian genome writing: Unlocking new length scales for genome engineering
Pinglay, S., Atwater, J. T., Brosh, R., Shendure, J., Maurano, M. T., & Boeke, J. D. (2026) · Cell · doi:10.1016/j.cell.2025.12.034 · Cited by 11
Super-Enhancers Dysregulations in Hematological Malignancies
Belloucif, Y., & Lobry, C. (2022) · Cells · doi:10.3390/cells11020196 · Cited by 10
Wang, H., Liu, Z., Wang, J., Hu, F., Zhou, Q., Wei, L., Bao, Q., Liang, J., Liang, J., Liu, Z., et al. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0919-0 · Cited by 9
Esearch3D: propagating gene expression in chromatin networks to illuminate active enhancers
Heer, M., Giudice, L., Mengoni, C., Giugno, R., & Rico, D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad229 · Cited by 8
Immune-epigenetic crosstalk in haematological malignancies
Wong, H., & Sugimura, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1233383 · Cited by 8
Zeng, Y.-P., Wei, R., Bao, L., Xue, T., Qin, Y., Ren, M., Bai, Q., Yao, Q., Yu, C., Chen, C., et al. (2024) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000002258 · Cited by 8
Iyer, A. R., Gurumurthy, A., Chu, A., Kodgule, R., Aguilar, A. R., Saari, T. W., Ramzan, A., Rosa, J., Gupta, J., Emmanuel, A., et al. (2025) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0126 · Cited by 9
Zhu, T., Li, C., & Chu, X. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2513371122 · Cited by 10
A super-enhancer maintains homeostatic expression of Regnase-1
Yang, R., Wu, Y., Ming, Y., Xu, Y., Wang, S., Shen, J., Wang, C., Chen, X., Wang, Y., Mao, R., et al. (2018) · Gene · doi:10.1016/j.gene.2018.05.052 · Cited by 8
Metadata
- Authors
- Bahr, C., von Paleske, L., Uslu, V. V., Remeseiro, S., Takayama, N., Ng, S. W., Murison, A., Langenfeld, K., Petretich, M., Scognamiglio, R., Zeisberger, P., Benk, A. S., Amit, I., Zandstra, P. W., Lupien, M., Dick, J. E., Trumpp, A., & Spitz, F.
- Affiliations
- German Cancer Research Center (DE)
- European Molecular Biology Laboratory (DE)
- University Health Network (CA)
- University of Toronto (CA)
- Weizmann Institute of Science (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Trumpp, Andreas
- Spitz, François
- ORCID
- Venue
- Nature
- Published
- 2018-01-17
- Volume
- 553
- Issue
- 7689
- Pages
- 515-520
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2783692764
- Cited by
- 328
- References
- 49
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 35 · 2023: 60 · 2022: 38 · 2021: 53 · 2020: 43 · 2019: 29 · 2018: 23
- FWCI
- 13.34
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-05-16)
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- c-Myc, super-enhancers, enhancer clusters, hematopoietic stem cells, hematopoietic progenitor cells, leukemia stem cells, acute myeloid leukemia, GFI1B, RUNX1, MYB, chromatin accessibility, transcriptional regulation
- MeSH terms
- Animals, B-Lymphocytes, Cell Differentiation, Chromatin, Enhancer Elements, Genetic, Female, Gene Expression Regulation, Multigene Family, Hematopoietic Stem Cells, Humans, Leukemia, Male, Mice, Inbred C57BL, Prognosis, Transcription Factors, Neoplastic Stem Cells, Leukemia, Myeloid, Acute, Down-Regulation, Survival Analysis, Genes, myc, Gene Deletion, Sequence Deletion, Cell Lineage, Myeloid Cells, Multipotent Stem Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review